Human MAIT cell profiles biased towards IL-17 or IL-10 are transient effector states directed by the cytokine milieuShow others and affiliations
2024 (English)In: European Journal of Immunology, ISSN 0014-2980, E-ISSN 1521-4141, Vol. 54, no Suppl. 1, p. 1128-1128, article id 680 - P2.0Article in journal, Meeting abstract (Other academic) Published
Abstract [en]
Mucosal-associated invariant T (MAIT) cells are unconventional MR1-restricted T cells mediating rapid innate-like antimicrobial immunity. However, how the functional heterogeneity of human MAIT cell responses is controlled is largely unclear. Here, combining functional and transcriptomic analyses we define distinct MAIT cell effector programs directed by the cytokine milieu during antigen recognition. Activation by TCR signaling together with IL-12 or IL-23 drives c-MAF-dependent IL-10 production, with intermediate levels of IFNγ/TNF, and elevated expression of TIM-3, LAG-3, and PD-1. The MAIT-derived IL-10 mediates both autocrine and paracrine immune regulation. In active Crohn’s disease, the MAIT cell IL-10 regulatory profile appears to be suppressed. In contrast to the action of IL-12, co-activation of MAIT cells with IL-18 strongly co-activates IL-17, GM-CSF, IFNγ and TNF, while counteracting IL-10 expression. Finally, TCR activation without cytokine co-activation drives primarily cytolytic arming. These activation states are transient and do not represent stable subsets. Altogether, these findings demonstrate how cytokine cues direct transient MAIT cell effector response programs.
Place, publisher, year, edition, pages
John Wiley & Sons, 2024. Vol. 54, no Suppl. 1, p. 1128-1128, article id 680 - P2.0
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:oru:diva-118530ISI: 001364287302319OAI: oai:DiVA.org:oru-118530DiVA, id: diva2:1928553
Conference
7th European Conference of Immunology, Dublin, Ireland, September 1-4, 2024
Funder
Swedish Research Council, 20020-01743; 2021-01764Swedish Cancer Society, 20-1142PjFSwedish Heart Lung Foundation, 2021044722Karolinska Institute
Note
This research was supported by grants to J.K.S. from the Swedish Research Council (2020-01743 and 2021-01764), the Swedish Cancer Society (20-1142PjF), the Swedish Heart-Lung Foundation (2021044722), and Karolinska Institutet. D.P.F. and J.Y.W.M were supported by Australian NHMRC Leadership Investigator (2009551), Australian Research Council (CE200100012), and US National Institutes of Health R01 (AI148407) grants.
2025-01-172025-01-172025-01-17Bibliographically approved